Events
 
Email Page
Opioid Legislation – The Path Forward for FDA and DEA
December 18, 2018

On December 18, Axinn partner Chad Landmon participated in the FDLI webinar, "Opioid Legislation – The Path Forward for FDA and DEA."

The webinar addressed the tools that The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act provide to FDA and DEA to combat the opioid crisis, real-world impacts of the legislation, and whether more federal action is necessary to alleviate the high rates of opioid overdoses and deaths in the US. 

Click here to access the webinar on-demand.